Strategic Industry Focus Agno Pharma (Eugene) operates in pharmaceutical manufacturing with capabilities in synthetic route optimization, process development, and scale-up, offering opportunities to sell advanced API development services, process improvements, and regulatory-compliant kilo to multi-kilo batch production.

Clinical Trial Readiness The company specializes in moving new APIs to clinical trials and provides intermediates, impurities, degradants, and reference standards, presenting a sales opening for CRO/CMO partnerships around early-phase development, analytical services, and supply of GMP-grade materials.

GMP Ready Capacity With 5 kg batch size capabilities in a GMP facility and kilo labs, there is potential to target small-to-mid scale manufacturing contracts, late-stage optimization, and tech transfer opportunities for clients seeking reliable, compliant production for Phase 1–2 programs.

Chemical Specialties Expertise spans alkaloids, heterocycles, steroids, terpenes, prostaglandins, chiral syntheses, and complex synthetic routes, enabling cross-selling of specialized building blocks, niche API ingredients, and custom synthesis for clients in life sciences, specialty chemicals, and agri-science.

Growth and Synergy As part of the broader Actylis context formed from multiple legacy firms, Agno Pharma can leverage integrated sourcing, R&D, and analytical capabilities to offer combined material supply chains, competitive pricing, and streamlined vendor solutions to large pharma and biotech customers.